Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 200 of 581 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 12/01/23
Due: 12/01/24
Phase: N/A
Priority: Normal
Start: 08/17/22
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 06/01/23
Due: 06/01/24
Phase: N/A
Priority: Normal
Start: 09/30/23
End: 09/01/27
Due: 09/01/28
Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer
Phase: N/A
Priority: Normal
Start: 10/05/15
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 09/30/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 08/31/17
Due: 08/31/18
Phase: N/A
Priority: Normal
Start: 07/01/23
End: 06/01/25
Due: 06/01/26
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 01/01/24
Due: 01/01/25
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 05/15/25
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 09/01/25
End: 09/01/29
Due: 09/01/30
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 01/03/25
End: 01/03/29
Due: 01/03/30
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 05/31/20
Due: 05/31/21
Phase: N/A
Priority: Normal
Start: 06/01/17
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 10/06/17
End: 03/23/18
Due: 03/23/19
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 08/25/25
End: 12/01/26
Due: 12/01/27
Phase: N/A
Priority: Normal
Start: 01/18/22
End: 11/30/25
Due: 11/30/26